Stockreport

Callan JMB Supports U.S. Scale-Up of Multi-Indication Immune Platform with Phase 2b/3 Advancement

Callan JMB Inc.  (CJMB) 
PDF Independent oversight reinforces manufacturing, supply chain integrity, and federal readiness for a platform designed to scale across multiple indications SPRING BRANCH [Read more]